Cardiovascular Systems Inc.
651 Campus Drive
St. Paul,
MN 55112-3495
United States - Map
Phone: 651-259-1600
Fax: 612-677-3355
Website: http://www.csi360.com
Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The company markets and sells its products through direct sales force to hospitals and office-based laboratories in the United States. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota. Key Statistics
| |
| Cardiovascular Systems Inc.’s ISS Governance QuickScore as of May 1, 2013 is 9. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 7; Compensation: 10. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. David L. Martin ,
49
Chief Exec. Officer, Pres and Director | 700.00K | 0.00 | Mr. Laurence L. Betterley ,
59
Chief Financial Officer, Principal Accounting Officer and Assistant Treasurer | 375.00K | 0.00 | Mr. James E. Flaherty CPA,
59
Chief Admin. Officer, Compliance Officer and Sec. | 335.00K | 0.00 | Mr. Kevin J. Kenny ,
48
Exec. VP of Sales & Marketing | 622.00K | 0.00 | Mr. Robert J. Thatcher ,
58
Exec. VP | 354.00K | 0.00 |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.12%